Mirum Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good afternoon. My name is Jeff Fye. I'm a senior biotech analyst at JPMorgan, and we're continuing the 40th JPMorgan Healthcare Conference today with Mirum. I'm joined by the company's CEO, Chris Peetz, who's going to give a presentation on the company, and then we'll go into some Q&A. (Operator Instructions) So without any further delay, let me turn it over to Chris Peetz.
Thanks, Jess. Thanks for hosting us this year as well. And I appreciate everybody's interest in Mirum Pharmaceuticals. It's an exciting time for us, and I'll go through some of our updates as well as a little background on our programs. But first, just to kick off, I'll be making forward-looking statements. So we would refer you to our SEC filings for more complete disclosure on risk factors and other information on the company. Calling out some page numbers as we go through the corporate deck here and starting on Page 3. Mirum is a
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
